ArticleTherapeutic advances in medical oncology2026
Serum levels of the C-terminal pro-peptide of type V collagen have prognostic potential and are associated with a normal subtype of desmoplasia in a retrospective cohort of patients with esophagogastric cancer.
Article in Therapeutic advances in medical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The role of stroma in esophagogastric cancer is ambiguous, with both tumor-promoting and tumor-restrictive properties. Several non-invasive biomarkers of stroma have recently been identified, but their relationship with stromal composition and clinical outcome in esophagogastric cancer remains insufficiently understood. Objectives: We aimed to investigate the association of serum stromal biomarkers with overall survival and stroma composition in esophagogastric cancers. Design: Eleven stromal biomarkers were retrospectively measured in pre-treatment serum of 78 patients with esophagogastric cancer and 11 healthy controls. Methods: Elastic net Cox regression was applied to associate serum concentration of stromal biomarkers with overall survival in patients with esophagogastric cancer. These associations were later confirmed with Kaplan-Meier curves and multivariate Cox regression analysis. RNA-sequencing was performed on 17 matched tumor biopsies and an independent validation cohort of 100 pre-treatment biopsies to explore the relation between stromal biomarker and stromal subtype. Results: This study revealed that serum formation fragment of collagen V as a stromal biomarker was high in patients with esophagogastric cancer compared to healthy subjects. A high serum concentration of the formation fragment of collagen V was independently prognostically favorable in patients with esophagogastric cancer. The formation of collagen V correlated with a distinct normal stroma subtype in the matched tumor biopsies. A gene signature specific for the formation fragment of collagen V was also independently prognostically favorable and correlated with a normal stroma subtype in the validation cohort. Conclusion: In conclusion, the formation of collagen V reflects a distinct normal stroma subtype in patients with esophagogastric cancer that associates with favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.